David Meek takes the helm at Ipsen July 18 as its new CEO. He had headed oncology programs at Baxalta Inc., now part of Shire PLC following the June close of its acquisition.
Iroko Pharmaceuticals LLC President Louis Vollmer adds the CEO title. Company founder and outgoing CEO Osagie Imasogie remains as...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?